Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
Uncategorised
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
HDFC Mutual Fund · Managed by Dhruv Muchhal; Nikhil Mathur
64steady
Latest NAV
₹22.3000
as of 18 Aug 2026
AUM
—
Expense ratio
1.08%
as of 30 Jun 2026
Inception
14 May 2026
FundScore
64/100steady
Rank #369 of 1015 · top 36%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
3.67%
3M
11.31%
6M
24.46%
1Y
25.46%
3Y CAGR
—
5Y CAGR
—
Since incep.
32.35%
Fund details
- Fund manager
- Dhruv Muchhal; Nikhil Mathur
- Riskometer
- Very High Risk
- Type
- Open Ended
- Portfolio turnover
- 42%
- Volatility (3Y)
- 14.1%
- Rating (external)
- —
Investment objective
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Stock holdings
Latest portfolio disclosure for this scheme.
No data yet
This fund hasn't disclosed a portfolio snapshot yet.